nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00335	0.00335	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00332	0.00332	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00331	0.00331	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—PENK—narcolepsy	0.00324	0.00324	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00319	0.00319	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00317	0.00317	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—HCRTR2—narcolepsy	0.00311	0.00311	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—HCRTR1—narcolepsy	0.00311	0.00311	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—HCRTR2—narcolepsy	0.0031	0.0031	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—HCRTR1—narcolepsy	0.0031	0.0031	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—HCRTR2—narcolepsy	0.00307	0.00307	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—HCRTR1—narcolepsy	0.00307	0.00307	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—P2RY11—narcolepsy	0.00301	0.00301	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—P2RY11—narcolepsy	0.003	0.003	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00299	0.00299	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00298	0.00298	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCRs, Other—HTR2A—narcolepsy	0.00298	0.00298	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—P2RY11—narcolepsy	0.00297	0.00297	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00296	0.00296	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCRs, Other—HTR2A—narcolepsy	0.00295	0.00295	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—TRH—narcolepsy	0.00287	0.00287	CbGpPWpGaD
Trihexyphenidyl—CHRM1—G alpha (q) signalling events—TAC1—narcolepsy	0.00279	0.00279	CbGpPWpGaD
Trihexyphenidyl—CHRM1—G alpha (q) signalling events—NPS—narcolepsy	0.00279	0.00279	CbGpPWpGaD
Trihexyphenidyl—CHRM3—G alpha (q) signalling events—TAC1—narcolepsy	0.00278	0.00278	CbGpPWpGaD
Trihexyphenidyl—CHRM3—G alpha (q) signalling events—NPS—narcolepsy	0.00278	0.00278	CbGpPWpGaD
Trihexyphenidyl—CHRM2—G alpha (i) signalling events—HRH3—narcolepsy	0.00277	0.00277	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—TRH—narcolepsy	0.00275	0.00275	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Circadian rythm related genes—NPS—narcolepsy	0.00264	0.00264	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00263	0.00263	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00263	0.00263	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—HCRTR2—narcolepsy	0.00261	0.00261	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—HCRTR1—narcolepsy	0.00261	0.00261	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00261	0.00261	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0026	0.0026	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00257	0.00257	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—HCRT—narcolepsy	0.00256	0.00256	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—HCRT—narcolepsy	0.00255	0.00255	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00255	0.00255	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00254	0.00254	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—HCRT—narcolepsy	0.00252	0.00252	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—P2RY11—narcolepsy	0.00252	0.00252	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—HRH3—narcolepsy	0.00252	0.00252	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—HCRTR1—narcolepsy	0.0025	0.0025	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—HCRTR2—narcolepsy	0.0025	0.0025	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.0025	0.0025	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.0025	0.0025	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00249	0.00249	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00249	0.00249	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—P2RY11—narcolepsy	0.00241	0.00241	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—HRH3—narcolepsy	0.00241	0.00241	CbGpPWpGaD
Trihexyphenidyl—CHRM5—G alpha (q) signalling events—HTR2A—narcolepsy	0.00239	0.00239	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—HCRTR2—narcolepsy	0.00237	0.00237	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—HCRTR1—narcolepsy	0.00237	0.00237	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—P2RY11—narcolepsy	0.00229	0.00229	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—PENK—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—PENK—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—HCRTR2—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—HCRTR1—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—PENK—narcolepsy	0.00225	0.00225	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00223	0.00223	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00223	0.00223	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0022	0.0022	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—P2RY11—narcolepsy	0.00219	0.00219	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—HCRT—narcolepsy	0.00214	0.00214	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00213	0.00213	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—TAC1—narcolepsy	0.00209	0.00209	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—NPS—narcolepsy	0.00209	0.00209	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—HCRT—narcolepsy	0.00205	0.00205	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—TAC1—narcolepsy	0.002	0.002	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—NPS—narcolepsy	0.002	0.002	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—HCRT—narcolepsy	0.00195	0.00195	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—TRH—narcolepsy	0.00194	0.00194	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—TRH—narcolepsy	0.00193	0.00193	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00193	0.00193	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00192	0.00192	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.00191	0.00191	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—PENK—narcolepsy	0.00191	0.00191	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—HCRT—narcolepsy	0.00186	0.00186	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00185	0.00185	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00185	0.00185	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00184	0.00184	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00184	0.00184	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00184	0.00184	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—PENK—narcolepsy	0.00183	0.00183	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00183	0.00183	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00183	0.00183	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00176	0.00176	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00176	0.00176	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—PENK—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.0017	0.0017	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—HRH3—narcolepsy	0.0017	0.0017	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—P2RY11—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—HRH3—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Trihexyphenidyl—CHRM1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00168	0.00168	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.00168	0.00168	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.00168	0.00168	CbGpPWpGaD
Trihexyphenidyl—CHRM3—G alpha (q) signalling events—HTR2A—narcolepsy	0.00167	0.00167	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—PENK—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00165	0.00165	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—TRH—narcolepsy	0.00162	0.00162	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.0016	0.0016	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.0016	0.0016	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—HCRTR2—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—HCRTR1—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00158	0.00158	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.00158	0.00158	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.00158	0.00158	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—TRH—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—P2RY11—narcolepsy	0.00154	0.00154	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—P2RY11—narcolepsy	0.00154	0.00154	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.00152	0.00152	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.0015	0.0015	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.0015	0.0015	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—TRH—narcolepsy	0.00148	0.00148	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—HCRT—narcolepsy	0.00145	0.00145	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—HCRT—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.00143	0.00143	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—HRH3—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—TRH—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—TAC1—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—NPS—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—TAC1—narcolepsy	0.0014	0.0014	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—NPS—narcolepsy	0.0014	0.0014	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HCRTR1—narcolepsy	0.0014	0.0014	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HCRTR2—narcolepsy	0.0014	0.0014	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—HRH3—narcolepsy	0.00136	0.00136	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—P2RY11—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HCRTR1—narcolepsy	0.00134	0.00134	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HCRTR2—narcolepsy	0.00134	0.00134	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—HCRT—narcolepsy	0.00131	0.00131	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—HCRT—narcolepsy	0.00131	0.00131	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.0013	0.0013	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.0013	0.0013	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—P2RY11—narcolepsy	0.0013	0.0013	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—HRH3—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—PENK—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—PENK—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CHKB—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—HTR2A—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—HRH3—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—HTR2A—narcolepsy	0.0012	0.0012	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—NPS—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—TAC1—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—PENK—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—PENK—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—PENK—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HCRT—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—NPS—narcolepsy	0.00113	0.00113	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—TAC1—narcolepsy	0.00113	0.00113	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00111	0.00111	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00111	0.00111	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HCRT—narcolepsy	0.0011	0.0011	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.0011	0.0011	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—TRH—narcolepsy	0.0011	0.0011	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—TRH—narcolepsy	0.00109	0.00109	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—TRH—narcolepsy	0.00108	0.00108	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—NPS—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—TAC1—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—NPS—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—TAC1—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PENK—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—TRH—narcolepsy	0.000995	0.000995	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—TRH—narcolepsy	0.000992	0.000992	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—TRH—narcolepsy	0.000982	0.000982	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PENK—narcolepsy	0.000982	0.000982	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—HRH3—narcolepsy	0.000961	0.000961	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—HRH3—narcolepsy	0.000958	0.000958	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	0.000948	0.000948	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HCRTR2—narcolepsy	0.000944	0.000944	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HCRTR1—narcolepsy	0.000944	0.000944	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HCRTR2—narcolepsy	0.000941	0.000941	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HCRTR1—narcolepsy	0.000941	0.000941	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	0.000932	0.000932	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	0.000932	0.000932	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—P2RY11—narcolepsy	0.000912	0.000912	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—P2RY11—narcolepsy	0.000909	0.000909	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—P2RY11—narcolepsy	0.0009	0.0009	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—HRH3—narcolepsy	0.000872	0.000872	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TRH—narcolepsy	0.000872	0.000872	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—HRH3—narcolepsy	0.00087	0.00087	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CPT1B—narcolepsy	0.000869	0.000869	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—HRH3—narcolepsy	0.000861	0.000861	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—HTR2A—narcolepsy	0.000847	0.000847	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—HTR2A—narcolepsy	0.000845	0.000845	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	0.000836	0.000836	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TRH—narcolepsy	0.000835	0.000835	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000825	0.000825	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—NPS—narcolepsy	0.000796	0.000796	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—TAC1—narcolepsy	0.000796	0.000796	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—TAC1—narcolepsy	0.000793	0.000793	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—NPS—narcolepsy	0.000793	0.000793	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	0.000786	0.000786	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—NPS—narcolepsy	0.000786	0.000786	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HCRT—narcolepsy	0.000775	0.000775	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HCRT—narcolepsy	0.000773	0.000773	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HCRT—narcolepsy	0.000765	0.000765	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HRH3—narcolepsy	0.000764	0.000764	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HRH3—narcolepsy	0.000732	0.000732	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—TAC1—narcolepsy	0.000723	0.000723	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—NPS—narcolepsy	0.000723	0.000723	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—NPS—narcolepsy	0.000721	0.000721	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—TAC1—narcolepsy	0.000721	0.000721	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—NPS—narcolepsy	0.000714	0.000714	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—TAC1—narcolepsy	0.000714	0.000714	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—HTR2A—narcolepsy	0.00071	0.00071	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PENK—narcolepsy	0.000691	0.000691	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PENK—narcolepsy	0.000689	0.000689	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PENK—narcolepsy	0.000682	0.000682	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—HTR2A—narcolepsy	0.00068	0.00068	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—HTR2A—narcolepsy	0.000645	0.000645	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NPS—narcolepsy	0.000633	0.000633	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TAC1—narcolepsy	0.000633	0.000633	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—HTR2A—narcolepsy	0.000618	0.000618	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TAC1—narcolepsy	0.000606	0.000606	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NPS—narcolepsy	0.000606	0.000606	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TRH—narcolepsy	0.000588	0.000588	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TRH—narcolepsy	0.000586	0.000586	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TRH—narcolepsy	0.00058	0.00058	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HRH3—narcolepsy	0.000515	0.000515	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HRH3—narcolepsy	0.000514	0.000514	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HRH3—narcolepsy	0.000509	0.000509	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.000479	0.000479	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—HTR2A—narcolepsy	0.000477	0.000477	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	0.000473	0.000473	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—HTR2A—narcolepsy	0.000435	0.000435	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—HTR2A—narcolepsy	0.000433	0.000433	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	0.000429	0.000429	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NPS—narcolepsy	0.000427	0.000427	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TAC1—narcolepsy	0.000427	0.000427	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TAC1—narcolepsy	0.000426	0.000426	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NPS—narcolepsy	0.000426	0.000426	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TAC1—narcolepsy	0.000421	0.000421	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NPS—narcolepsy	0.000421	0.000421	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HTR2A—narcolepsy	0.000381	0.000381	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HTR2A—narcolepsy	0.000365	0.000365	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HTR2A—narcolepsy	0.000257	0.000257	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HTR2A—narcolepsy	0.000256	0.000256	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HTR2A—narcolepsy	0.000254	0.000254	CbGpPWpGaD
